ino-4800
Vaccineexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Apr 3, 2020 (NCT04336410)
Timeline
Indications
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05430958 | Phase 1 | Oct 31, 2022 | Inovio Pharmaceuticals |
| NCT04642638 | Phase 2/Phase 3 (Phase 3) | Nov 30, 2020 | Inovio Pharmaceuticals |
| NCT04447781 | Phase 1/Phase 2 (Phase 2) | Jul 15, 2020 | Coalition for Epidemic Preparedness Innovations, Inovio Pharmaceuticals, International Vaccine Institute, Seoul National University |
| NCT04336410 | Phase 1 | Apr 3, 2020 | Coalition for Epidemic Preparedness Innovations, Inovio Pharmaceuticals |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Inovio Pharmaceuticals | For profit | 4 | 3 | 3 | 2020 |
| Coalition for Epidemic Preparedness Innovations | Academic/Hospital | 2 | 0 | 2 | 2020 |
| International Vaccine Institute | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Seoul National University | Academic/Hospital | 1 | 0 | 1 | 2020 |
4 organizations
Page 1 / 1